✓ verbatim from the press ◦ composed from multiple sources
About 40,000 Brazilians live with multiple sclerosis — a neurological disease that mainly affects young women and requires continuous treatment to prevent disabilities. On World Multiple Sclerosis Day, celebrated this Saturday (30th), specialists reinforce the importance of early diagnosis to stabilize disease progression. ✓
Press quotes (1)
"Segundo a Associação Brasileira de Esclerose Múltipla (ABEM), cerca de 40 mil brasileiros convivem atualmente com a doença."
Multiple sclerosis is an autoimmune condition that affects the central nervous system, compromising brain, spinal cord and optic nerves. According to a scientific review published in 2025, prevalence in Brazil is 14.5 cases per 100,000 inhabitants, with regional variations between 4.5 and 30.7 cases. The disease mainly emerges between ages 20 and 50, peaking at 30, and is twice as frequent in women. ✓
Press quotes (1)
"A revisão sistemática "Prevalence of multiple sclerosis in Brazil: An updated systematic review with meta-analysis", publicada em 2025 na revista científica Clinical Neurology and Neurosurgery, estimou prevalência agrupada de 14,5 casos por 100 mil habitantes no país, com variações regionais entre 4,5 e 30,7 casos por 100 mil habitantes."
The Unified Health System offers free medications for treatment, including fingolimod (Gilenya), approved by Anvisa for patients with relapsing-remitting multiple sclerosis after therapeutic failure with beta-interferon or glatiramer acetate. To access treatment, patients must undergo medical evaluation in SUS and complete the Medication Request, Evaluation and Authorization Form. ◦
Press quotes (1)
"Tecnologia: cloridrato de fingolimode (GilenyaTM). Indicação: tratamento de pacientes adultos com esclerose múltipla remitente-recorrente, após falha terapêutica de betainterferona ou acetato de glatirâmer... Já o fingolimode, foi incorporado ao SUS após recomendação da Conitec do ano de 2013, apresenta-se como uma quarta opção de tratamento aos pacientes que não estejam aptos ao uso do natalizumabe."
Symptoms include intense fatigue, visual changes, tingling, muscle weakness and imbalance. Specialists warn that many patients live for months or years with neurological symptoms treated as temporary. Regular follow-up with neurologists, supervised physical activities and mental health care are fundamental to maintaining quality of life. ✓
Press quotes (1)
"Os sintomas da esclerose múltipla podem variar de pessoa para pessoa e surgir de forma intermitente, o que costuma atrasar a procura por avaliação especializada. Fadiga intensa, alterações visuais, formigamentos, fraqueza muscular, desequilíbrio, dificuldades motoras e alterações urinárias estão entre os sinais mais comuns."
Multiple sclerosis mainly affects young women between 20-50 years
WHO estimates over 2.8 million people with multiple sclerosis worldwide
Covered by only some sources, or where the accounts diverge.
Covered by only some sources (1)
Every five minutes, someone receives a multiple sclerosis diagnosis worldwide
-
What are the specific costs of multiple sclerosis medications in SUS?
Why it's still unknown: Articles mention treatment is available for free in SUS, but don't detail the costs involved or budget impact.
-
What is the comparative efficacy of different medications available in SUS?
Why it's still unknown: Sources cite fingolimod as an option after therapeutic failure, but don't present data on success rates or treatment comparisons.